Article
Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer.
Cancer biology & therapy - 1 Jul 2010
Gao Rui, Price Douglas K, Dahut William L, Reed Eddie, Figg William D
Abstract excerpt
Radiation therapy is a potentially curative, important treatment option in localized prostate cancer. However, at 8 years after radiation therapy, even in the best risk subset of patients, approximately 10% of patients will experience clinical disease recurrence. The identification of molecular markers of treatment success or failure may allow for the development of strategies to further improve treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
